X0306 4 2021-06-21 0000748592 Brooklyn ImmunoTherapeutics, Inc. BTX 0001618457 Gurrola Sandra M C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220 true Vice President of Finance Restricted Stock Unit 2021-06-21 4 A 0 35000 0 A Common Stock 35000 35000 D Each restricted stock unit represents a contingent right to receive one share of common stock. The option vests and becomes exercisable in four equal installments on June 21 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Ms. Gurrola's Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021), subject to continued service through each vesting date. /s/ Mark L. Johnson, Attorney-in-Fact for Sandra M. Gurrola 2021-06-22